Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome

Abstract

The invention belongs to the technical field of traditional Chinese medicine and particularly relates to application of a medicine composition containing folium artemisiae argyi to preparing medicine for treating the irritable bowel syndrome.The medicine composition is prepared from, by weight, 13-28 parts of folium artemisiae argyi, 20-24 parts of roxburgh roses, 11-19 parts of malt, 11-17 parts of cortex phellodendri, 6-15 parts of radix astragali, 8-17 parts of flos carthami, 6-14 parts of coix seeds, 9-18 parts of Chinese yam, 3-12 parts of fructus aurantii immaturus, 5-21 parts of poria cocos, 3-12 parts of radix angelica sinensis, 4-9 parts of lotus seeds and 6-10 parts of licorice roots.The medicine composition accords with the compatibility principles of monarch, minister, assistant and guide, components are reasonable, major and minor components are clear, and the components mutually gain.The medicines are coordinating and have the functions of invigorating the spleen and strengthening mid-energy, removing dampness and removing stagnancy, clearing dampness and promoting diuresis, harmonizing intestines and the stomach, promoting qi circulation and promoting digestion and relieving distension and stopping diarrhea.Raw materials are low in cost, the preparation technology is simple, the treatment effect is good, pertinence is high, universality is good, safety is high, and the application is suitable for clinical popularization.

Description

technical field

[0001] The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to the use of a medicinal composition containing argyi leaves for preparing a medicine for treating irritable bowel syndrome. Background technique

[0002] Irritable bowel syndrome (IBS) refers to a group of clinical syndromes including abdominal pain, bloating, defecation habits and / or changes in stool characteristics, but lack of gastrointestinal structural and biochemical abnormalities. persistent or recurrent.

[0003] IBS is a high incidence of gastrointestinal disease. Epidemiological surveys show that 10%-20% of adults and adolescents in the world have IBS symptoms, more women than men, and the male-to-female ratio is between 1:1.2-1:2. The prevalence of IBS in Beijing and Guangzhou meeting Manning criteria and Rome II criteria were 7.01% and 5.6%, respectively. Although IBS is not life-threatening, it does cause thousands of patients to suf...

Examples

Embodiment 1

[0049] The pharmaceutical composition of Example 1 of the present invention includes the following preparation raw materials in parts by weight:

[0050] 13 parts of mugwort leaves, 20 parts of prickly pear, 11 parts of malt, 11 parts of treat servings and 6 servings of licorice.

[0051] The preparation method is as follows:

[0052] S1. Weigh each raw medicinal material, remove impurities, wash, dry, slice and pulverize into coarse powder;

[0053] S2, take the coarse powder of argyi leaves, place it in a supercritical carbon dioxide extraction device, add 45% of the total amount of coarse powder and 60% ethanol by volume, adjust the flow rate of carbon dioxide to be 15L / h, the extraction pressure is 20MPa, and the extraction temperature is 50°C, The extraction time was 2h, and the argyi leaf extract was obtained by separation under reduced pressure, and the argyi leaf dregs were retained;

[0054] S3. Take prickly pear, malt, phellodendron, astragalus, safflower, coix se...

Embodiment 2

[0059] The pharmaceutical composition of Example 2 of the present invention includes the following preparation raw materials in parts by weight:

[0060] 28 parts of mugwort leaves, 24 parts of prickly pear, 19 parts of malt, 17 parts of treat servings and 10 servings of licorice.

[0061] The preparation method is the same as in Example 1.

Embodiment 3

[0063] The pharmaceutical composition in Example 3 of the present invention includes the following preparation raw materials in parts by weight:

[0064] 21 parts of mugwort leaves, 22 parts of prickly pear, 15 parts of malt, 14 parts of treat servings and 13 servings of licorice.

[0065] The preparation method is the same as in Example 1.

technical field

[0001] The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to the use of a medicinal composition containing argyi leaves for preparing a medicine for treating irritable bowel syndrome. Background technique

[0002] Irritable bowel syndrome (IBS) refers to a group of clinical syndromes including abdominal pain, bloating, defecation habits and / or changes in stool characteristics, but lack of gastrointestinal structural and biochemical abnormalities. persistent or recurrent.

[0003] IBS is a high incidence of gastrointestinal disease. Epidemiological surveys show that 10%-20% of adults and adolescents in the world have IBS symptoms, more women than men, and the male-to-female ratio is between 1:1.2-1:2. The prevalence of IBS in Beijing and Guangzhou meeting Manning criteria and Rome II criteria were 7.01% and 5.6%, respectively. Although IBS is not life-threatening, it does cause thousands of patients to suf...

Examples

Embodiment 1

[0049] The pharmaceutical composition of Example 1 of the present invention includes the following preparation raw materials in parts by weight:

[0050] 13 parts of mugwort leaves, 20 parts of prickly pear, 11 parts of malt, 11 parts of treat servings and 6 servings of licorice.

[0051] The preparation method is as follows:

[0052] S1. Weigh each raw medicinal material, remove impurities, wash, dry, slice and pulverize into coarse powder;

[0053] S2, take the coarse powder of argyi leaves, place it in a supercritical carbon dioxide extraction device, add 45% of the total amount of coarse powder and 60% ethanol by volume, adjust the flow rate of carbon dioxide to be 15L / h, the extraction pressure is 20MPa, and the extraction temperature is 50°C, The extraction time was 2h, and the argyi leaf extract was obtained by separation under reduced pressure, and the argyi leaf dregs were retained;

[0054] S3. Take prickly pear, malt, phellodendron, astragalus, safflower, coix se...

Embodiment 2

[0059] The pharmaceutical composition of Example 2 of the present invention includes the following preparation raw materials in parts by weight:

[0060] 28 parts of mugwort leaves, 24 parts of prickly pear, 19 parts of malt, 17 parts of treat servings and 10 servings of licorice.

[0061] The preparation method is the same as in Example 1.

Embodiment 3

[0063] The pharmaceutical composition in Example 3 of the present invention includes the following preparation raw materials in parts by weight:

[0064] 21 parts of mugwort leaves, 22 parts of prickly pear, 15 parts of malt, 14 parts of treat servings and 13 servings of licorice.

[0065] The preparation method is the same as in Example 1.

Images